Correction: Sanofi insulin storyNEW YORK — In a story Sept. 20 about studies of a brand of insulin, The Associated Press reported erroneously that Sanofi-Aventis' drug Lantus is co-marketed by drugmaker Bristol-Myers Squibb. The drug is marketed by Sanofi-Aventis alone.